5443192026-04-035443192026-04-032026-04-03iso4217:INRxbrli:pureSENORES PHARMACEUTICALS LIMITEDSENORESNewAcquisition (including agreement to acquire)2026-04-022026-04-03SENORES PHARMACEUTICALS INC.OthersWHOLLY OWNED SUBSIDIARYAmerisyn, LLC000falsefalsefalsefalsePHARMACEUTICALSPursuant to the Operating Agreement (“Agreement”) dated April 02, 2026, the wholly owned subsidiary of the Company i.e., Senores Pharmaceuticals, Inc. (“SPI”), has subscribed to 70% membership interest in Amerisyn, LLC, which, accordingly, has become a step-down subsidiary of the Company. NAfalseNot ApplicableOthers70% of the total membership interest of the step-down subsidiary i.e. Amerisyn, LLC, has been subscribed by the wholly owned subsidiary of the Company i.e. Senores Pharmaceuticals, Inc. with effect from April 02, 2026.000.70.7Not Applicable2026-03-05United States of America